Funding news for global health researchers: December 16, 2024

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Just Announced Fogarty Funding Opportunities

New mHealth Opportunity from Fogarty

The overall goal of the program is to develop an evidence base for the use of mHealth technology to improve clinical and public health outcomes, and strengthen mHealth research capacity in LMICs.This NOFO provides support for up to two years for technology development and feasibility studies, followed by a possible transition to expanded research support for validation, larger-scale feasibility, and effectiveness studies.

• Application due date: March 21, 2025; March 20, 2026
• Read funding opportunity (PAR-25-242)
• Learn more about the mHealth program
  

Upcoming Deadlines for Fogarty Funding Opportunities

• Stigma HIV/AIDS
  Application deadline: December 20, 2024
  
• Japanese Research Fellowships (JSPS)
  Application deadline: February 14, 2025
  
• International Research Scientist Development Award (IRSDA)
  Application deadline: March 10, 2025
  

Upcoming deadlines for all Fogarty funding opportunities

Funding opportunities on which Fogarty is a partner:

• NIMHD Minority Health and Health Disparities Research Training (MHRT) Program (T37 Clinical Trial Not Allowed) (RFA-MD-25-001)
  Application due date: January 10, 2025
• Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) (PAR-25-233)
  Application due date: Multiple dates, see announcement.
• Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) (PAR-25-143)
  Application due date: Multiple dates, see announcement.

Administrative supplements for current Fogarty grant recipients:

• Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) (NOT-OD-25-015) 
  Expiration date: January 24, 2025
  
• Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) (PA-20-272) 
  Expiration date: January 24, 2025
  
• Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards (NOT-OD-23-032) 
  Expiration date: October 1, 2025
  
• Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) (PA-23-189) 
  Expiration date: May 8, 2026
  

All administrative supplements

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration:

• Integrating Mental Health Care into Health Care Systems and Non-Health Settings in Low- and Middle-Income Countries (R01 Clinical Trial Optional) (PAR-25-201)
  Application due date: Multiple dates, see announcement.
• Career Development Opportunities for Research on Cancer in Global Settings at the Center for Global Health at the National Cancer Institute  (NOT-CA-24-098)
  Application due date: Multiple dates, see announcement.
• Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Income Countries (LMICs) for Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed) (RFA-AG-25-031)
  Application due date: Multiple dates, see announcement.
• Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Trial Not Allowed) (RFA-AG-25-032)
  Application due date: Multiple dates, see announcement.

More NIH funding opportunities focused on areas relevant to global health

NIH funding opportunities for which foreign organizations and/or foreign components of U.S. organizations may apply:

• NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed) (PAR-25-045)
  Application due date: February 16, 2025
• Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) (PAR-25-224)
  Application due date: February 21, 2025
• Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) (PAR-25-028)
  Application due date: Multiple dates, see announcement.
• Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) (PAR-25-029)
  Application due date: Multiple dates, see announcement.
• High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) (PAR-25-277)
  Application due date: Multiple dates, see announcement.
• Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) (PAR-25-321)
  Application due date: Multiple dates, see announcement.
• Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) (PAR-25-325)
  Application due date: Multiple dates, see announcement.
• Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed) (PAR-25-330)
  Application due date: Multiple dates, see announcement.
• Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) (PAR-25-346)
  Application due date: Multiple dates, see announcement.
• BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) (RFA-EY-25-001)
  Application due date: Multiple dates, see announcement.

NIH funding opportunities for which foreign components may apply:

• Deriving Common Data Elements from Real-World Data for Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (U24 Clinical Trial Not Allowed) (RFA-AG-25-001)
  Application due date: February 14, 2025
• Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed) (PAR-24-287)
  Application due date: February 19, 2025
• Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional) (RFA-NR-25-003)
  Application due date: February 28, 2025
• Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional) (RFA-RM-24-010)
  Application due date: February 28, 2025
• Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) (PAR-25-157)
  Application due date: June 19, 2025
• Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) (PAR-24-279)
  Application due date: Multiple dates, see announcement.
• Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) (PAR-24-280)
  Application due date: Multiple dates, see announcement.
• Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) (PAR-24-289)
  Application due date: Multiple dates, see announcement.
• NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) (PAR-25-141)
  Application due date: Multiple dates, see announcement.
• HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) (PAR-25-154)
  Application due date: Multiple dates, see announcement.
• Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional) (PAR-25-155)
  Application due date: Multiple dates, see announcement.
• Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional) (PAR-25-156)
  Application due date: Multiple dates, see announcement.
• Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional) (PAR-25-196)
  Application due date: Multiple dates, see announcement.
• Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed) (PAR-25-197)
  Application due date: Multiple dates, see announcement.
• Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) (PAR-25-230)
  Application due date: Multiple dates, see announcement.
• Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) (PAR-25-296)
  Application due date: Multiple dates, see announcement.
• Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional) (PAR-25-317)
  Application due date: Multiple dates, see announcement.

Other Funding News

General Notices:

• Reminder of Updates to NIH Training Grant Application Data Tables for Application Due Dates on or After January 25, 2025 (NOT-OD-25-044)
• Notice of the Discontinuation of NCI's Participation in PA-23-262 "Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)” (NOT-CA-25-013)

Notices of changes to NIH funding opportunities:

• Notice of Change to Eligibility Information for PAR-24-297, "Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)" (NOT-DA-24-060)

NIH Notices of Special Interest (NOSIs):

• Innovative Interdisciplinary Research on Female Reproductive Aging (NOT-AG-24-074)
  Expiration date: May 8, 2028
  

Non-NIH funding opportunities:

• HealthTech Hub Africa is seeking ventures from across Africa with innovative solutions and business models allowing for collaboration with local and national governments and aiming to solve health challenges and/or support public health systems in their digital transformation.
  Application deadline: January 17, 2024

More non-NIH funding opportunities

Training Opportunities

Cornell Accepting Applications for Global Women’s Health Training

Applications are now open for the Global Infectious Diseases across a Woman's Lifespan Course, and the Women’s Infectious Diseases in Global Health Scholars (WINGS) Program. 

• Applications due: January 31, 2025
• Apply here
  

Manuscript, Abstract & Poster Submission Opportunities

• The International Cancer Screening Network (ICSN) is now accepting abstract submissions for ICSN 2025, which will be held June 18-20, 2025 in Aarhus, Denmark. The theme of ICSN 2025 is "Shaping the Future of Cancer Screening." Submitters are encouraged to submit abstracts that explore topics relating to one of the 10 abstracts themes.
  • Submissions due: January 2, 2025
• The National Cancer Institute is now accepting proposals for the annual ASGCR Symposium on Global Cancer Research. The theme of this year’s symposium is New Models for Participatory Research in Global Oncology: Elevating the Voices of Patients and Providers.
  • Symposium dates: May 5-8, 2025
  • Submissions due: January 17, 2025
• The Abstract Submission portal for INTEREST 2025, being held May 13-16, 2025, in Windhoek, Namibia, is now open. Successful candidates will be invited for an oral, mini-oral, or poster presentation.
  • Submissions due: January 17, 2025
• Beyond Global Health (BGH) is interested in how people from the Global North and Global South share their understanding of the concept of “Global Health.” Rather than exploring this through scientific journals and manuscripts, BGH is looking to expand on this idea through poetry, art, prose, and photography. Submissions are currently being accepted through the BGH website from researchers, participants, global health professionals, recipients of global health interventions, and anyone passionate about global health.
  • Submissions due: February 17, 2025

Events

Events for global health researchers:

• Emerging and Re-Emerging Infectious Diseases: A Perpetual Challenge

  • Date: January 7
  • Location: Virtual
  • Part of the 2025 Demystifying Medicine Series
  • Sponsored by FAES and NIH

Fogarty calendar of events